Conjunctival malignant melanoma treated successfully with BRAF inhibitor: encorafenib plus binimetinib
Authors:
Open Access
- 15 April 2022
- journal article
- research article
- Published by California Digital Library (CDL) in Dermatology Online Journal
- Vol. 28 (1)